Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nkx2-2
|
ENSMUSG00000027434.10 | NK2 homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_147186288_147186461 | Nkx2-2 | 30 | 0.947473 | -0.16 | 2.5e-01 | Click! |
chr2_147185785_147185936 | Nkx2-2 | 241 | 0.861942 | 0.12 | 3.8e-01 | Click! |
chr2_147186564_147186715 | Nkx2-2 | 235 | 0.812497 | -0.11 | 4.4e-01 | Click! |
chr2_147194050_147194201 | Nkx2-2 | 117 | 0.954972 | 0.10 | 4.8e-01 | Click! |
chr2_147194658_147195296 | Nkx2-2 | 734 | 0.605909 | -0.06 | 6.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_72761638_72761789 | 13.07 |
Gabrq |
gamma-aminobutyric acid (GABA) A receptor, subunit theta |
63465 |
0.09 |
chr14_22745616_22746275 | 12.33 |
Gm7473 |
predicted gene 7473 |
29299 |
0.24 |
chr6_65606922_65607109 | 12.19 |
Tnip3 |
TNFAIP3 interacting protein 3 |
9441 |
0.24 |
chr3_136738641_136738821 | 11.47 |
4930599N24Rik |
RIKEN cDNA 4930599N24 gene |
21229 |
0.19 |
chr18_24420261_24420672 | 11.19 |
Mir187 |
microRNA 187 |
8704 |
0.22 |
chr9_59684059_59684343 | 11.16 |
Gramd2 |
GRAM domain containing 2 |
4057 |
0.16 |
chr11_17171024_17171178 | 10.60 |
Wdr92 |
WD repeat domain 92 |
11006 |
0.17 |
chr17_10362088_10362266 | 10.48 |
1700110C19Rik |
RIKEN cDNA 1700110C19 gene |
37575 |
0.17 |
chr14_101794840_101795087 | 10.18 |
Lmo7 |
LIM domain only 7 |
34005 |
0.17 |
chr9_62689868_62690019 | 10.06 |
Itga11 |
integrin alpha 11 |
12083 |
0.23 |
chr16_38705952_38706240 | 9.34 |
Arhgap31 |
Rho GTPase activating protein 31 |
6802 |
0.16 |
chr11_8500924_8501101 | 9.18 |
Tns3 |
tensin 3 |
32337 |
0.24 |
chr12_77151612_77151767 | 9.09 |
Gm22696 |
predicted gene, 22696 |
35257 |
0.17 |
chr17_10361844_10362008 | 9.09 |
1700110C19Rik |
RIKEN cDNA 1700110C19 gene |
37324 |
0.17 |
chr16_95932968_95933119 | 8.99 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
3966 |
0.21 |
chr3_118869813_118869964 | 8.99 |
Gm43410 |
predicted gene 43410 |
1644 |
0.51 |
chr13_93992771_93993277 | 8.93 |
Gm47216 |
predicted gene, 47216 |
1256 |
0.46 |
chr8_122092580_122092736 | 8.57 |
Banp |
BTG3 associated nuclear protein |
91811 |
0.06 |
chr10_66752330_66752675 | 8.56 |
Gm47895 |
predicted gene, 47895 |
6952 |
0.16 |
chr11_8345014_8345192 | 8.51 |
Gm11989 |
predicted gene 11989 |
38750 |
0.21 |
chr11_87039587_87039738 | 8.49 |
Gdpd1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
34400 |
0.09 |
chr17_7654039_7654243 | 8.45 |
Gm49632 |
predicted gene, 49632 |
8813 |
0.23 |
chr6_82956881_82957091 | 8.33 |
Gm19287 |
predicted gene, 19287 |
4206 |
0.11 |
chr11_100120399_100120550 | 8.30 |
Krt13 |
keratin 13 |
103 |
0.91 |
chr16_57569043_57569375 | 8.28 |
Filip1l |
filamin A interacting protein 1-like |
19967 |
0.21 |
chr13_119263615_119263950 | 8.28 |
Gm44488 |
predicted gene, 44488 |
5822 |
0.24 |
chr16_85748095_85748429 | 8.26 |
Adamts1 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
51376 |
0.15 |
chr11_83740671_83740822 | 8.17 |
Wfdc21 |
WAP four-disulfide core domain 21 |
6194 |
0.1 |
chr16_92674190_92674488 | 8.11 |
Runx1 |
runt related transcription factor 1 |
21156 |
0.21 |
chr11_85843373_85844045 | 8.11 |
Gm11444 |
predicted gene 11444 |
6624 |
0.13 |
chr9_106326298_106326486 | 8.09 |
Poc1a |
POC1 centriolar protein A |
1336 |
0.33 |
chr9_62995124_62995631 | 7.99 |
Pias1 |
protein inhibitor of activated STAT 1 |
7453 |
0.21 |
chr3_118869417_118869570 | 7.94 |
Gm43410 |
predicted gene 43410 |
1249 |
0.6 |
chr10_111794932_111795111 | 7.93 |
Gm47865 |
predicted gene, 47865 |
4730 |
0.15 |
chr5_67595068_67595219 | 7.87 |
1700025A08Rik |
RIKEN cDNA 1700025A08 gene |
12683 |
0.14 |
chr16_10300291_10300442 | 7.86 |
Emp2 |
epithelial membrane protein 2 |
13505 |
0.14 |
chr7_127925119_127925602 | 7.77 |
Prss8 |
protease, serine 8 (prostasin) |
4735 |
0.07 |
chr18_8216009_8216249 | 7.73 |
Gm20147 |
predicted gene, 20147 |
11877 |
0.24 |
chr19_21859258_21859479 | 7.63 |
Gm50130 |
predicted gene, 50130 |
25612 |
0.19 |
chr5_103620346_103620572 | 7.58 |
Gm15844 |
predicted gene 15844 |
4012 |
0.16 |
chr8_103203783_103204084 | 7.53 |
Gm45391 |
predicted gene 45391 |
58987 |
0.14 |
chr1_136561909_136562079 | 7.52 |
Gm33994 |
predicted gene, 33994 |
17483 |
0.12 |
chr4_83214787_83215095 | 7.50 |
Ttc39b |
tetratricopeptide repeat domain 39B |
18229 |
0.18 |
chr15_33366247_33366398 | 7.39 |
1700084J12Rik |
RIKEN cDNA 1700084J12 gene |
39617 |
0.21 |
chr2_33054117_33054327 | 7.36 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
19438 |
0.15 |
chr8_64221721_64221872 | 7.32 |
Tll1 |
tolloid-like |
15525 |
0.25 |
chr2_34515303_34515576 | 7.26 |
Gm13408 |
predicted gene 13408 |
49560 |
0.12 |
chr1_14223475_14223633 | 7.16 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
7938 |
0.22 |
chrX_164440232_164440416 | 7.15 |
Asb11 |
ankyrin repeat and SOCS box-containing 11 |
2266 |
0.27 |
chr2_174754368_174754536 | 7.15 |
Edn3 |
endothelin 3 |
6167 |
0.24 |
chr3_34908627_34908778 | 7.09 |
Mir6378 |
microRNA 6378 |
13949 |
0.24 |
chr18_37891113_37891264 | 7.05 |
Diaph1 |
diaphanous related formin 1 |
6754 |
0.1 |
chr3_116414476_116414803 | 7.02 |
Cdc14a |
CDC14 cell division cycle 14A |
8010 |
0.16 |
chr5_127310428_127310665 | 6.96 |
9430087B13Rik |
RIKEN cDNA 9430087B13 gene |
1529 |
0.44 |
chr6_125433714_125434059 | 6.95 |
Cd9 |
CD9 antigen |
29138 |
0.12 |
chr16_38624391_38624551 | 6.91 |
Tmem39a |
transmembrane protein 39a |
36432 |
0.12 |
chr2_113534586_113534746 | 6.86 |
Gm13964 |
predicted gene 13964 |
30632 |
0.17 |
chr6_101275882_101276171 | 6.85 |
9530086O07Rik |
RIKEN cDNA 9530086O07 gene |
12484 |
0.18 |
chr7_128321291_128321673 | 6.81 |
Gm6916 |
predicted pseudogene 6916 |
6698 |
0.11 |
chr6_18248492_18248868 | 6.78 |
Cftr |
cystic fibrosis transmembrane conductance regulator |
6544 |
0.2 |
chr16_95777149_95777300 | 6.73 |
Gm37259 |
predicted gene, 37259 |
17388 |
0.16 |
chr15_60618977_60619128 | 6.70 |
Gm48946 |
predicted gene, 48946 |
51291 |
0.14 |
chr2_164449524_164449675 | 6.69 |
Sdc4 |
syndecan 4 |
5712 |
0.09 |
chr9_14544447_14544660 | 6.66 |
Amotl1 |
angiomotin-like 1 |
14498 |
0.12 |
chr9_56260137_56260407 | 6.65 |
Peak1os |
pseudopodium-enriched atypical kinase 1, opposite strand |
2382 |
0.2 |
chr9_62502540_62502691 | 6.63 |
Coro2b |
coronin, actin binding protein, 2B |
7883 |
0.22 |
chr8_33905789_33906327 | 6.60 |
Rbpms |
RNA binding protein gene with multiple splicing |
14294 |
0.16 |
chr11_86022501_86022733 | 6.57 |
Gm11443 |
predicted gene 11443 |
72122 |
0.1 |
chr16_17945139_17945601 | 6.55 |
Slc25a1 |
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 |
17151 |
0.09 |
chr2_73654410_73654564 | 6.49 |
Chn1 |
chimerin 1 |
571 |
0.73 |
chr4_145026429_145026974 | 6.47 |
Vps13d |
vacuolar protein sorting 13D |
24333 |
0.2 |
chr7_112289469_112289834 | 6.46 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
18352 |
0.26 |
chr19_36167625_36167790 | 6.43 |
Gm32081 |
predicted gene, 32081 |
14873 |
0.19 |
chr16_95848554_95849066 | 6.38 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
3040 |
0.25 |
chr19_26745483_26745907 | 6.38 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
486 |
0.85 |
chr5_130192469_130192665 | 6.37 |
Ndufa12-ps |
NADH:ubiquinone oxidoreductase subunit A12, pseudogene |
4172 |
0.12 |
chr8_14660294_14660574 | 6.37 |
Dlgap2 |
DLG associated protein 2 |
82319 |
0.09 |
chr5_77126733_77126884 | 6.36 |
Gm15831 |
predicted gene 15831 |
4460 |
0.15 |
chr1_24613351_24614205 | 6.35 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr5_136394928_136395103 | 6.33 |
Mir721 |
microRNA 721 |
19212 |
0.16 |
chr9_79997288_79997439 | 6.33 |
Gm8131 |
predicted gene 8131 |
6475 |
0.18 |
chr11_106426539_106426705 | 6.33 |
Icam2 |
intercellular adhesion molecule 2 |
38547 |
0.1 |
chr13_18038862_18039076 | 6.30 |
Gm6575 |
predicted gene 6575 |
408 |
0.76 |
chr16_86595022_86595216 | 6.30 |
Gm49572 |
predicted gene, 49572 |
163780 |
0.04 |
chr5_7436657_7436808 | 6.28 |
Gm4960 |
predicted gene 4960 |
36370 |
0.19 |
chr8_128219019_128219170 | 6.26 |
Mir21c |
microRNA 21c |
59131 |
0.15 |
chr5_139877666_139877831 | 6.23 |
Gm42423 |
predicted gene 42423 |
18061 |
0.13 |
chr17_6803718_6803869 | 6.20 |
4933426B08Rik |
RIKEN cDNA 4933426B08 gene |
4716 |
0.17 |
chr10_34246421_34246589 | 6.16 |
Gm47485 |
predicted gene, 47485 |
916 |
0.43 |
chr14_60815280_60815431 | 6.16 |
Mipep |
mitochondrial intermediate peptidase |
30717 |
0.15 |
chr6_34035134_34035436 | 6.14 |
Lrguk |
leucine-rich repeats and guanylate kinase domain containing |
4023 |
0.27 |
chr19_14894963_14895137 | 6.12 |
Gm5513 |
predicted pseudogene 5513 |
65716 |
0.15 |
chr4_123623801_123623952 | 6.09 |
Gm12926 |
predicted gene 12926 |
6419 |
0.15 |
chr7_105621908_105622059 | 6.06 |
Gm45632 |
predicted gene 45632 |
2721 |
0.12 |
chr14_61613210_61613361 | 6.03 |
Kcnrg |
potassium channel regulator |
5803 |
0.09 |
chr1_85163919_85164982 | 6.03 |
Gm6264 |
predicted gene 6264 |
3587 |
0.13 |
chr1_90904224_90904580 | 6.03 |
Mlph |
melanophilin |
10683 |
0.16 |
chr4_151805205_151805408 | 6.02 |
Camta1 |
calmodulin binding transcription activator 1 |
56344 |
0.13 |
chr4_82359302_82359453 | 5.95 |
n-R5s188 |
nuclear encoded rRNA 5S 188 |
80033 |
0.1 |
chr7_66183527_66183831 | 5.95 |
Gm45080 |
predicted gene 45080 |
6876 |
0.16 |
chr7_73769343_73769494 | 5.95 |
Fam174b |
family with sequence similarity 174, member B |
3482 |
0.14 |
chr11_61535669_61535820 | 5.93 |
Gm12272 |
predicted gene 12272 |
7989 |
0.13 |
chr1_74624463_74624614 | 5.93 |
Stk36 |
serine/threonine kinase 36 |
1708 |
0.24 |
chr14_99850491_99850681 | 5.92 |
Gm5958 |
predicted pseudogene 5958 |
14772 |
0.21 |
chr5_134644858_134645082 | 5.91 |
Eif4h |
eukaryotic translation initiation factor 4H |
5480 |
0.13 |
chr5_103620180_103620344 | 5.88 |
Gm15844 |
predicted gene 15844 |
4209 |
0.16 |
chr14_14351950_14353283 | 5.87 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr5_76437185_76437354 | 5.85 |
Gm42665 |
predicted gene 42665 |
14505 |
0.15 |
chr5_34902982_34903304 | 5.85 |
Msantd1 |
Myb/SANT-like DNA-binding domain containing 1 |
4869 |
0.2 |
chr5_91607966_91608133 | 5.80 |
Parm1 |
prostate androgen-regulated mucin-like protein 1 |
90434 |
0.07 |
chr4_76661867_76662090 | 5.80 |
Gm11242 |
predicted gene 11242 |
30165 |
0.21 |
chr5_31931244_31931395 | 5.79 |
Gm43811 |
predicted gene 43811 |
4622 |
0.27 |
chr1_151427167_151427469 | 5.78 |
Swt1 |
SWT1 RNA endoribonuclease homolog (S. cerevisiae) |
1118 |
0.3 |
chr18_58543308_58543459 | 5.78 |
Slc27a6 |
solute carrier family 27 (fatty acid transporter), member 6 |
12874 |
0.27 |
chr19_5615072_5615223 | 5.75 |
Kat5 |
K(lysine) acetyltransferase 5 |
4910 |
0.09 |
chr1_183133639_183133882 | 5.75 |
Disp1 |
dispatched RND transporter family member 1 |
13701 |
0.21 |
chr11_90577464_90577811 | 5.74 |
Stxbp4 |
syntaxin binding protein 4 |
28727 |
0.16 |
chr3_27156208_27156579 | 5.73 |
1700125G22Rik |
RIKEN cDNA 1700125G22 gene |
2367 |
0.23 |
chr2_44286375_44286600 | 5.71 |
Gm22867 |
predicted gene, 22867 |
142448 |
0.05 |
chr18_62101761_62102177 | 5.71 |
Gm41750 |
predicted gene, 41750 |
40649 |
0.16 |
chr16_4835282_4835433 | 5.70 |
4930562C15Rik |
RIKEN cDNA 4930562C15 gene |
59 |
0.96 |
chr6_64581354_64581539 | 5.69 |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
81742 |
0.1 |
chr15_79690079_79691459 | 5.66 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr11_46085507_46085658 | 5.66 |
Mir8100 |
microRNA 8100 |
16688 |
0.12 |
chr6_146686107_146686317 | 5.65 |
4930479D17Rik |
RIKEN cDNA 4930479D17 gene |
28994 |
0.11 |
chr11_93434983_93435328 | 5.65 |
Gm24856 |
predicted gene, 24856 |
21831 |
0.28 |
chr15_55043599_55043825 | 5.62 |
Taf2 |
TATA-box binding protein associated factor 2 |
2454 |
0.24 |
chr1_134784075_134784234 | 5.62 |
Ppp1r12b |
protein phosphatase 1, regulatory subunit 12B |
857 |
0.52 |
chr12_83965252_83965549 | 5.61 |
Gm26571 |
predicted gene, 26571 |
14045 |
0.09 |
chr12_12509201_12509901 | 5.61 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
116936 |
0.06 |
chr5_20559421_20559572 | 5.60 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
25158 |
0.2 |
chr9_66219027_66219209 | 5.57 |
Dapk2 |
death-associated protein kinase 2 |
1629 |
0.44 |
chr12_100323780_100323931 | 5.56 |
Ttc7b |
tetratricopeptide repeat domain 7B |
9054 |
0.18 |
chr5_77398374_77398543 | 5.56 |
Igfbp7 |
insulin-like growth factor binding protein 7 |
9582 |
0.14 |
chr8_116509312_116509470 | 5.56 |
Dynlrb2 |
dynein light chain roadblock-type 2 |
4376 |
0.28 |
chr11_105310185_105310476 | 5.56 |
Mrc2 |
mannose receptor, C type 2 |
17662 |
0.18 |
chr1_85259970_85261058 | 5.55 |
C130026I21Rik |
RIKEN cDNA C130026I21 gene |
1556 |
0.27 |
chr11_84952643_84952794 | 5.55 |
Car4 |
carbonic anhydrase 4 |
5068 |
0.17 |
chr1_161914060_161914211 | 5.53 |
Gm31925 |
predicted gene, 31925 |
21988 |
0.13 |
chr4_136143104_136143903 | 5.53 |
Id3 |
inhibitor of DNA binding 3 |
6 |
0.97 |
chr10_20486899_20487265 | 5.52 |
Gm17229 |
predicted gene 17229 |
31082 |
0.17 |
chr2_3154403_3154614 | 5.50 |
Fam171a1 |
family with sequence similarity 171, member A1 |
35823 |
0.17 |
chr8_24429899_24430312 | 5.49 |
Gm26714 |
predicted gene, 26714 |
7701 |
0.15 |
chr15_63065959_63066540 | 5.49 |
Gm30159 |
predicted gene, 30159 |
74158 |
0.1 |
chr19_56663933_56664084 | 5.48 |
Gm32441 |
predicted gene, 32441 |
603 |
0.71 |
chr13_81089992_81090512 | 5.48 |
Gm18517 |
predicted gene, 18517 |
2688 |
0.21 |
chrX_133735991_133736142 | 5.48 |
Pcdh19 |
protocadherin 19 |
47079 |
0.16 |
chr18_65094057_65094239 | 5.46 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
11094 |
0.24 |
chr4_148734678_148734838 | 5.43 |
Gm13203 |
predicted gene 13203 |
21055 |
0.17 |
chr3_60267443_60267736 | 5.43 |
Tgif1-ps |
TGFB-induced factor homeobox 1, pseudogene |
75504 |
0.1 |
chr2_34960511_34960662 | 5.42 |
Traf1 |
TNF receptor-associated factor 1 |
976 |
0.41 |
chr9_64260076_64260227 | 5.41 |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
6520 |
0.11 |
chr8_15060959_15061237 | 5.41 |
Myom2 |
myomesin 2 |
908 |
0.42 |
chr4_128427657_128427887 | 5.39 |
Csmd2 |
CUB and Sushi multiple domains 2 |
49382 |
0.16 |
chr19_40767323_40767474 | 5.39 |
Cc2d2b |
coiled-coil and C2 domain containing 2B |
6972 |
0.19 |
chr14_121116740_121117033 | 5.37 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
14807 |
0.27 |
chr10_116701397_116701548 | 5.37 |
Gm26579 |
predicted gene, 26579 |
26881 |
0.13 |
chr14_17005513_17005684 | 5.34 |
Gm18078 |
predicted gene, 18078 |
51992 |
0.14 |
chr13_31055393_31055575 | 5.34 |
Gm48662 |
predicted gene, 48662 |
22361 |
0.18 |
chr13_71980040_71980191 | 5.33 |
Irx1 |
Iroquois homeobox 1 |
16392 |
0.24 |
chr4_139387042_139387343 | 5.33 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
6523 |
0.12 |
chr5_113755480_113755940 | 5.32 |
Sart3 |
squamous cell carcinoma antigen recognized by T cells 3 |
268 |
0.85 |
chr5_72927230_72927381 | 5.31 |
Gm9870 |
predicted gene 9870 |
12363 |
0.13 |
chr17_10363232_10363383 | 5.31 |
1700110C19Rik |
RIKEN cDNA 1700110C19 gene |
38705 |
0.17 |
chr1_190886153_190886305 | 5.29 |
Rps6kc1 |
ribosomal protein S6 kinase polypeptide 1 |
13488 |
0.18 |
chr8_35968385_35968710 | 5.29 |
Gm22030 |
predicted gene, 22030 |
9031 |
0.22 |
chr9_29776677_29776828 | 5.28 |
Gm15521 |
predicted gene 15521 |
184242 |
0.03 |
chr18_7484321_7484472 | 5.27 |
Mpp7 |
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
18223 |
0.23 |
chr7_112268723_112268946 | 5.26 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
2465 |
0.41 |
chr7_75553079_75553230 | 5.26 |
Gm44835 |
predicted gene 44835 |
7460 |
0.21 |
chr3_89314502_89314658 | 5.24 |
Gm15998 |
predicted gene 15998 |
859 |
0.32 |
chr9_9037345_9037496 | 5.22 |
Gm16485 |
predicted gene 16485 |
65629 |
0.13 |
chr14_101838552_101838703 | 5.21 |
Lmo7 |
LIM domain only 7 |
115 |
0.98 |
chr5_102770596_102770892 | 5.21 |
Arhgap24 |
Rho GTPase activating protein 24 |
1973 |
0.48 |
chr15_94689298_94689449 | 5.20 |
Gm25546 |
predicted gene, 25546 |
7987 |
0.26 |
chr5_38630316_38630467 | 5.19 |
Zfp518b |
zinc finger protein 518B |
54359 |
0.1 |
chr3_105000743_105000894 | 5.19 |
Gm40117 |
predicted gene, 40117 |
6786 |
0.16 |
chr2_35072642_35072932 | 5.19 |
Hc |
hemolytic complement |
11349 |
0.15 |
chr3_82980665_82980816 | 5.18 |
Gm30097 |
predicted gene, 30097 |
14845 |
0.15 |
chr12_72554445_72554719 | 5.17 |
Pcnx4 |
pecanex homolog 4 |
18199 |
0.17 |
chr6_120635376_120635527 | 5.17 |
Cecr2 |
CECR2, histone acetyl-lysine reader |
30918 |
0.13 |
chr16_87208080_87208231 | 5.16 |
Gm32865 |
predicted gene, 32865 |
79716 |
0.1 |
chr10_69595600_69595751 | 5.15 |
Gm46231 |
predicted gene, 46231 |
29314 |
0.21 |
chr7_144609698_144609863 | 5.15 |
Ano1 |
anoctamin 1, calcium activated chloride channel |
1485 |
0.38 |
chr14_110224817_110224979 | 5.15 |
n-R5s50 |
nuclear encoded rRNA 5S 50 |
63063 |
0.15 |
chr2_144768758_144769081 | 5.15 |
Gm11743 |
predicted gene 11743 |
12590 |
0.2 |
chr1_88437865_88438060 | 5.14 |
Gm28888 |
predicted gene 28888 |
21721 |
0.13 |
chr11_105352233_105352567 | 5.14 |
Gm11638 |
predicted gene 11638 |
10852 |
0.17 |
chr4_139256810_139256991 | 5.12 |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
23517 |
0.12 |
chr11_62814478_62814629 | 5.12 |
Trim16 |
tripartite motif-containing 16 |
5678 |
0.12 |
chr6_145457135_145457443 | 5.10 |
Lmntd1 |
lamin tail domain containing 1 |
6522 |
0.16 |
chr13_104656829_104656980 | 5.10 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
28027 |
0.23 |
chr7_80554187_80554617 | 5.09 |
Blm |
Bloom syndrome, RecQ like helicase |
19283 |
0.14 |
chr4_100435665_100436137 | 5.08 |
Ube2u |
ubiquitin-conjugating enzyme E2U (putative) |
42948 |
0.16 |
chr9_67247492_67247646 | 5.08 |
Mir190a |
microRNA 190a |
10843 |
0.21 |
chr16_95382153_95382455 | 5.06 |
Gm31641 |
predicted gene, 31641 |
26628 |
0.2 |
chr4_139176000_139176429 | 5.05 |
Gm16287 |
predicted gene 16287 |
4441 |
0.16 |
chr3_69375079_69375261 | 5.05 |
Gm17212 |
predicted gene 17212 |
39410 |
0.13 |
chr1_82717941_82718092 | 5.04 |
Col4a3 |
collagen, type IV, alpha 3 |
2712 |
0.16 |
chr7_112012674_112012825 | 5.03 |
Usp47 |
ubiquitin specific peptidase 47 |
10755 |
0.26 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 7.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.9 | 3.8 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.5 | 6.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
1.5 | 4.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.4 | 1.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.4 | 4.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.3 | 5.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.2 | 4.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.2 | 3.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.2 | 3.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.2 | 6.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.2 | 4.7 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.2 | 3.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.2 | 3.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.1 | 3.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.1 | 2.2 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
1.1 | 2.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.1 | 3.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.1 | 3.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.0 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
1.0 | 3.0 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.0 | 4.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.0 | 4.0 | GO:0070836 | caveola assembly(GO:0070836) |
1.0 | 3.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.0 | 2.0 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.0 | 3.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.9 | 4.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 3.8 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.9 | 2.8 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.9 | 2.8 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.9 | 4.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.9 | 2.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.9 | 3.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.9 | 2.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.9 | 2.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.9 | 2.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.9 | 2.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.9 | 1.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.9 | 2.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.9 | 0.9 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.9 | 6.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.9 | 2.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.9 | 6.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.9 | 2.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.9 | 4.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.9 | 2.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.8 | 3.4 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.8 | 2.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.8 | 3.3 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.8 | 0.8 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.8 | 2.5 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.8 | 4.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 2.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.8 | 0.8 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.8 | 1.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.8 | 1.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.8 | 3.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.8 | 3.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 2.3 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.7 | 2.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.7 | 2.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 1.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.7 | 10.3 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.7 | 8.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.7 | 4.4 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.7 | 3.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.7 | 4.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.7 | 2.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.7 | 0.7 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.7 | 2.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.7 | 1.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 6.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.7 | 0.7 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.7 | 1.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.7 | 3.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.7 | 1.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.7 | 6.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.7 | 3.3 | GO:0015705 | iodide transport(GO:0015705) |
0.7 | 2.0 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.7 | 2.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.7 | 1.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.6 | 5.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.6 | 0.6 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.6 | 1.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.6 | 3.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.6 | 1.8 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.6 | 0.6 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.6 | 3.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.6 | 2.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.6 | 3.0 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.6 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.6 | 1.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 1.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 1.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.6 | 0.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 2.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.6 | 3.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 1.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 1.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.6 | 1.7 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.6 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.6 | 2.2 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.7 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.6 | 1.7 | GO:0060066 | oviduct development(GO:0060066) |
0.6 | 3.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.6 | 2.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 4.4 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 1.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.5 | 2.7 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.5 | 1.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 1.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.5 | 1.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 2.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 0.5 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 2.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 2.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 1.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.5 | 2.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 2.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.5 | 1.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 4.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 2.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 2.1 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.5 | 1.0 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.5 | 3.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.5 | 2.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 2.5 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.5 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.5 | 2.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 1.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.5 | 2.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.5 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 1.5 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 1.9 | GO:0046959 | habituation(GO:0046959) |
0.5 | 1.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 1.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.5 | 3.9 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.5 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.5 | 1.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.5 | 2.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 2.4 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.5 | 2.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 1.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.5 | 1.9 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.5 | 0.5 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.5 | 1.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 1.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.5 | 4.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.5 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 2.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 1.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 3.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 0.9 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.4 | 0.9 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.4 | 3.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 1.3 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.4 | 1.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.4 | 2.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 0.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 | 1.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 0.9 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.4 | 1.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 0.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.4 | 3.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 0.4 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.4 | 0.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 0.4 | GO:0001705 | ectoderm formation(GO:0001705) |
0.4 | 0.4 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 2.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 2.9 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 4.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.4 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 0.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 1.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.4 | 3.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 1.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.4 | 0.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.4 | 1.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 8.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.4 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 2.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 0.8 | GO:0036394 | amylase secretion(GO:0036394) |
0.4 | 1.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.4 | 1.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 1.2 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.4 | 2.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.4 | 3.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 5.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 1.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.4 | 0.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 16.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.4 | 1.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 1.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 1.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.4 | 1.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.4 | 1.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 1.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 1.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 1.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 1.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.4 | 0.7 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.4 | 1.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 1.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 1.1 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.4 | 1.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 0.4 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.4 | 0.4 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.4 | 3.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 2.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 0.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.4 | 1.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 1.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.4 | 2.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 1.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.4 | 5.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 4.0 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.4 | 1.1 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.4 | 3.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 0.7 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 2.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.4 | 0.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 0.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.4 | 1.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 1.7 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.3 | 1.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 1.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 1.7 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.3 | 0.3 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) cell-cell signaling involved in cell fate commitment(GO:0045168) negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.3 | 1.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 1.4 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 7.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.3 | 0.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 0.7 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.3 | 1.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 0.3 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.3 | 3.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 2.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 3.0 | GO:0002076 | osteoblast development(GO:0002076) |
0.3 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 1.3 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.3 | 1.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 0.6 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 0.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.3 | 6.7 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 3.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.3 | 0.3 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.3 | 1.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 0.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 0.6 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
0.3 | 1.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 5.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 1.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 0.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 2.5 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.3 | 5.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 2.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 4.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.3 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 1.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 1.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 0.9 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 1.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 0.3 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.3 | 0.6 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.9 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 1.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 1.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 1.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 0.3 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.3 | 3.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 0.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 2.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 0.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 1.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.6 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 0.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 1.4 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.3 | 0.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.3 | 0.6 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 0.6 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 0.3 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.3 | 0.9 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 1.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 0.6 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 0.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 0.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 1.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 1.1 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 0.8 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.3 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.6 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.3 | 0.3 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.3 | 0.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 0.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 1.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.8 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.3 | 0.5 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.3 | 3.0 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.3 | 1.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 2.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 0.3 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.3 | 1.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 1.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 1.3 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 0.8 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.8 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 0.3 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.3 | 0.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 0.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 0.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 1.8 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.3 | 1.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 1.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 1.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 1.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 0.8 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.3 | 1.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 0.5 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.3 | 0.8 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 1.2 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.7 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 1.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.2 | 1.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.7 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.2 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 1.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.7 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.5 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.9 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 0.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.7 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 0.9 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.2 | 1.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.2 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.5 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 1.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 0.9 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.2 | 1.1 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.2 | 0.5 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.2 | 1.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.9 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 1.8 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.2 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 0.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 2.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 3.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.4 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.2 | 0.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 0.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 2.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 2.3 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 1.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.2 | 0.6 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 1.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.2 | 0.8 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.2 | 1.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 0.2 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 2.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.2 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.2 | 2.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.2 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.2 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 1.8 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.2 | 1.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.4 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 0.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 1.0 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.4 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.2 | 0.2 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.2 | 0.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 2.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 3.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 1.4 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 1.6 | GO:0097369 | sodium ion import(GO:0097369) |
0.2 | 0.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 3.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 5.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.8 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.8 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.2 | 0.6 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 0.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 0.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 2.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 1.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.9 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 1.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:0060268 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 1.1 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.2 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.5 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.2 | 0.5 | GO:0019230 | proprioception(GO:0019230) |
0.2 | 0.5 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.7 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.7 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.2 | 3.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 1.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 0.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
0.2 | 0.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 0.2 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.2 | 2.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.2 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.2 | 2.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.2 | 0.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 0.9 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.5 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.9 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 1.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.2 | 0.3 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.3 | GO:0090186 | regulation of pancreatic juice secretion(GO:0090186) |
0.2 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 2.0 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.2 | 1.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 2.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.7 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 1.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 0.3 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 1.0 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 1.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 0.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.2 | 0.3 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.3 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.2 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.2 | 0.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 1.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 1.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.2 | 0.2 | GO:0003284 | septum primum development(GO:0003284) |
0.2 | 1.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 1.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 0.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 0.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 1.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 1.0 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.4 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:1901213 | regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901213) |
0.1 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.4 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 1.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 3.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.1 | 0.4 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.4 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.1 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.1 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.3 | GO:0060440 | trachea formation(GO:0060440) regulation of Golgi inheritance(GO:0090170) |
0.1 | 1.0 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.7 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.4 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.4 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 2.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 3.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 1.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.1 | 0.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) regulation of cell proliferation in bone marrow(GO:0071863) |
0.1 | 0.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 1.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.3 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 1.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 1.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.4 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 2.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.1 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.8 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.1 | 0.2 | GO:0072538 | T-helper 17 type immune response(GO:0072538) positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.5 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.3 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 1.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.2 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.6 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.6 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 1.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 1.1 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 0.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.8 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 1.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.1 | 1.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 1.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.5 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.2 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 2.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 1.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.1 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.3 | GO:0006499 | N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.5 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.6 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.4 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.1 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 0.6 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.1 | 2.9 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 6.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 1.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.2 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.1 | 0.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 1.3 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 1.5 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 1.7 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 0.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.2 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.7 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.1 | 0.1 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.3 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.3 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.1 | 0.2 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.2 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.1 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0003171 | atrioventricular valve development(GO:0003171) |
0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 1.5 | GO:0046854 | lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.1 | 0.5 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.1 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.7 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.2 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.5 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.1 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:0048570 | notochord formation(GO:0014028) notochord morphogenesis(GO:0048570) |
0.1 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.3 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.3 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.9 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.8 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.6 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.1 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.1 | 0.3 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.6 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.2 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.5 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.1 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.2 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.5 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.1 | 0.1 | GO:0051024 | regulation of eosinophil degranulation(GO:0043309) positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.7 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 1.2 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 1.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 1.0 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.1 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.1 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.2 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.1 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.7 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.1 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.1 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.3 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.4 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 1.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.1 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.2 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.0 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.0 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.0 | 0.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.0 | 0.1 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.5 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.2 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.0 | 0.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.0 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.6 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.0 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 1.0 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.3 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.0 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.0 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.0 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.1 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.0 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.0 | 0.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.5 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.2 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.0 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.4 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.8 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.0 | GO:0046386 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.0 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.5 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.4 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.5 | GO:1903844 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.0 | 0.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.0 | 0.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.2 | GO:0001938 | regulation of endothelial cell proliferation(GO:0001936) positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0061743 | motor learning(GO:0061743) |
0.0 | 0.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.0 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.0 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:0097427 | microtubule bundle(GO:0097427) |
1.5 | 4.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.4 | 4.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.2 | 4.9 | GO:0005955 | calcineurin complex(GO:0005955) |
1.0 | 2.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.0 | 4.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.0 | 2.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 6.0 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.9 | 4.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.9 | 3.7 | GO:0071203 | WASH complex(GO:0071203) |
0.8 | 3.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.8 | 3.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.7 | 3.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 11.0 | GO:0031430 | M band(GO:0031430) |
0.7 | 2.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.7 | 4.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 1.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 4.6 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.6 | 2.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 1.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 4.5 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 7.2 | GO:0002102 | podosome(GO:0002102) |
0.5 | 2.2 | GO:0035363 | histone locus body(GO:0035363) |
0.5 | 5.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 3.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 1.9 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 2.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.5 | 4.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 3.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.5 | 1.8 | GO:0044308 | axonal spine(GO:0044308) |
0.4 | 1.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 1.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 24.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 0.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.4 | 5.1 | GO:0043034 | costamere(GO:0043034) |
0.4 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 0.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) phagocytic vesicle membrane(GO:0030670) |
0.4 | 3.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 0.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 3.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 21.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.4 | 1.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 1.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 2.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 10.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 1.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 4.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.7 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 2.7 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 1.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.3 | 0.9 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 0.9 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 1.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 4.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 0.9 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 3.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 0.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 1.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 0.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 0.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 20.7 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 0.8 | GO:0005712 | chiasma(GO:0005712) |
0.3 | 0.8 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 2.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 2.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 9.2 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 1.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 6.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 1.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 2.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.9 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 2.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 1.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 8.3 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 9.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 7.1 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 2.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.3 | GO:0002177 | manchette(GO:0002177) |
0.2 | 1.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 2.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.2 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 2.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 2.7 | GO:0031672 | A band(GO:0031672) |
0.2 | 2.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 4.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 2.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.8 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.2 | 4.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 11.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 2.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 2.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 46.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 1.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.7 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 4.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 1.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.5 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.8 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 1.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 35.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 1.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.5 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.4 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 1.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 7.9 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 2.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 1.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 2.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 8.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 2.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 4.9 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 1.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 5.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 3.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 6.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 1.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.9 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 3.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0005818 | aster(GO:0005818) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 2.4 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 2.7 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 8.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 2.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.5 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.0 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.0 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.3 | 4.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.2 | 3.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.2 | 3.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.0 | 7.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.0 | 2.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.0 | 5.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.0 | 2.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 6.7 | GO:0018653 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.9 | 6.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.9 | 2.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.9 | 0.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.9 | 5.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.9 | 5.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.8 | 2.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 3.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 2.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 9.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.8 | 3.8 | GO:0071253 | connexin binding(GO:0071253) |
0.8 | 2.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 0.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.7 | 5.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 2.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 3.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 1.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.7 | 4.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.7 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.7 | 2.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 3.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.7 | 2.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 5.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 2.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 1.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 1.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 1.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 7.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 6.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.6 | 2.3 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.6 | 2.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 1.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.5 | 1.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 1.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 1.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 0.5 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.5 | 5.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 1.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 10.8 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 1.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 3.6 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.5 | 3.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 1.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 1.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 1.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 1.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 1.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 0.9 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.4 | 1.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 1.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 1.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 4.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 2.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 1.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 1.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 2.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 1.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 1.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 1.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 3.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 3.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 1.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 4.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 11.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 1.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 3.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 1.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.4 | 5.0 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 0.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 1.5 | GO:0044682 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 1.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 5.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 4.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 1.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 1.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 0.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 5.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 8.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 1.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 2.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 13.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 1.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 1.7 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 1.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 1.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 2.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 1.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 1.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 4.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 2.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 1.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 1.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 2.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 2.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.3 | 1.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 6.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.3 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 15.4 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 1.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 1.5 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.3 | 1.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 0.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 3.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 5.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 2.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.3 | 1.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 0.9 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 1.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 3.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 0.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 2.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 2.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 2.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 2.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 1.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 0.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 0.8 | GO:0035877 | death effector domain binding(GO:0035877) |
0.3 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 0.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 0.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.3 | 1.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 0.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 0.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 3.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 3.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 6.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.2 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.2 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 2.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 3.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 0.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 1.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 2.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.2 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 3.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 2.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.6 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.2 | 2.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 1.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 3.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 1.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 1.0 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 2.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 2.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 1.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 1.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 1.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.4 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.7 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.2 | 1.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.7 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.2 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 5.1 | GO:0032934 | sterol binding(GO:0032934) |
0.2 | 1.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 1.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 3.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 2.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.6 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 3.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 1.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 1.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 4.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 2.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 2.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 12.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 1.2 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.4 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 1.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 2.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 2.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 1.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 33.9 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.1 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 1.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 2.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 5.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.9 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 4.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 1.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.4 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.9 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 1.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 1.1 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.8 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 1.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.5 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 1.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 2.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.4 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 2.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 1.7 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 2.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 1.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.4 | GO:0052850 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.3 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) peptidoglycan binding(GO:0042834) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 1.6 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.2 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 3.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 2.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.5 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 5.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 1.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 1.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 1.8 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 3.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 1.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 1.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 2.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.7 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 2.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 1.2 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 2.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 14.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 6.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 18.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 17.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 8.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 16.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 1.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 3.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 3.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 1.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 6.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 3.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 12.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 9.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 3.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 4.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 7.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 7.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 13.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 5.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 4.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 4.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 5.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 6.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 6.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 4.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 7.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 3.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 3.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 9.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 5.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 1.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 0.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 4.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 23.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 3.7 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 1.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 21.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 2.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 3.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 0.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 6.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 5.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 7.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.6 | 2.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.5 | 4.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 2.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 4.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 9.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 21.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 2.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.4 | 6.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 1.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 5.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 5.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 1.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 6.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 2.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 0.6 | REACTOME MAP KINASE ACTIVATION IN TLR CASCADE | Genes involved in MAP kinase activation in TLR cascade |
0.3 | 2.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 5.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 1.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 3.0 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 5.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 3.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 24.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 2.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 4.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 4.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 1.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 1.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 0.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.8 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 3.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 5.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 2.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 2.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 15.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 1.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 9.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 3.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 1.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 1.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 8.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 2.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 5.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 1.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 3.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 1.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 5.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 2.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.3 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 1.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 0.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 0.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 4.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.8 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |